380 filings
Page 2 of 19
8-K
sanz3mkd 56vjbtqkk3
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
8-K
pfu oj7f313shfiexos2
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
SC 13D/A
yqymgb78vkfq3
17 Apr 24
AVENUE THERAPEUTICS / Fortress Biotech ownership change
4:05pm
4
kuiuq3bii94
17 Apr 24
Change in insider ownership
4:05pm
8-K
o43 obwizg
29 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2:41pm
DEF 14C
epedxd5 l9e12
18 Mar 24
Information statement
4:59pm
8-K
a8g0 1ev4avb
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
8-K
eq0jnbwv
15 Mar 24
Other Events
7:15am
PRE 14C
75dwie8snm
8 Mar 24
Preliminary information
4:31pm
8-K
dd692
8 Mar 24
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
3h0zzy68jqz1jgae
23 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:17pm
EFFECT
z4b qog9na5cyyl15
2 Feb 24
Notice of effectiveness
12:15am
424B3
osna3zbl2 567p9
2 Feb 24
Prospectus supplement
12:00am
CORRESP
5fvjhrkh0iyb5ub3rfo
30 Jan 24
Correspondence with SEC
12:00am
DEF 14C
1hde2plw
29 Jan 24
Information statement
8:00am
UPLOAD
tsu afmsl
29 Jan 24
Letter from SEC
12:00am
PRE 14C
ebokd 9bjsp
17 Jan 24
Preliminary information
5:05pm
8-K
x67awrrrr
12 Jan 24
Submission of Matters to a Vote of Security Holders
6:01am